|Title:||Thienamycin renal peptidase inhibitors|
|Abstract:||Novel chemical compounds are provided which selectively inhibit the metabolism of dipeptidase (E.C.220.127.116.11) and therefore are useful in combination with antibacterial products. These chemical compounds are z-2-acylamino-3-monosubstituted propenoates.|
|Inventor(s):||Graham; Donald W. (Mountainside, NJ), Rogers; Edward F. (Middletown, NJ), Kahan; Frederick M. (Scotch Plains, NJ)|
|Assignee:||Merck & Co., Inc. (Rahway, NJ)|
Patent Claim Types:|
see list of patent claims
|Compound; Composition; Use;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.